Systemic immunomodulatory therapy in severe dry eye secondary to inflammation

Ocular Immunology and Inflammation

Volumn 15, Issue 2, 2007, Pages 99-104

  Cordero Coma, Miguel ^a,b   Anzaar, Fahd ^a   Sobrin, Lucia ^a,c   Foster, C Stephen ^a,c,d  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b HOSPITAL DE LEÓN   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Massachusetts Eye Research and Surgery Institute   (United States)

Author keywords

Dry eye disease; Immunosuppressive agents; Keratitis sicca; Lacrimal gland; Ocular surface inflammation; Sjogren's syndrome

Indexed keywords

BOTULINUM TOXIN A; CYCLOSPORIN; CYCLOSPORIN A; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; MOXIFLOXACIN; PREDNISOLONE ACETATE; PREDNISONE; ROSE BENGAL;

ADD ON THERAPY; ADULT; ARTICLE; BLEPHAROSPASM; CASE REPORT; CASE STUDY; CONVALESCENCE; DARKNESS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRY EYE; EYE CARE; EYE INFLAMMATION; EYE PAIN; EYELID; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATOCONJUNCTIVITIS SICCA; LACRIMAL GLAND DISEASE; LUBRICATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHOTOPHOBIA; PSORIASIS; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; SCHIRMER TEST; SJOEGREN SYNDROME; STAINING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; DRY EYE SYNDROMES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; METHOTREXATE; MIDDLE AGED; PREDNISONE; PSORIASIS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250192888     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940701299354     Document Type: Article

References (19)

1. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114-1119.
2. Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthamol. 1997;124:723-728.
3. Fox RI. Pathogenesis of Sjogren's syndrome. Rheum Dis Clin North Am. 1992;18:517-538.
4. Gordon TP, Bolstad AI, Rischmueller M, et al. Autoantibodies in primary Sjogren's syndrome: New insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity. 2001;34:123-132.
5. Zoukhri D, Hodges RR, Byon D, et al. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci. 2002;43:1429-1436.
6. Plugfelder SC. Perspective, anti-inflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337-342.
7. Sullivan DA, Belanguer A, Cermark JM, et al. Are women with Sjogren's syndrome androgen deficient?. J Rheumatol. 2003;30:2413-2419.
8. Nagler RM, Pollack S. Sjogren's syndrome induced by estrogen therapy. Semin Arthritis Rheum. 2000;30:209-214.
9. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
10. Hakala M, Niemela RK. Does autonomic nervous impairment have a role in pathophysiology of Sjogren's syndrome?. Lancet. 2000;355:1032-1033.
11. Fox RI. Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjogren's syndrome. Adv Exp Med Biol. 2002;506:1107-1116.
12. Toker E, Yavuz S, Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br J Ophthalmol. 2004;88:384-387.
13. Manthorpe R, Frost-Larsen K, Isager H, et al. Sjogren's syndrome: A review with emphasis on immunological features. Allergy. 1981;36:139-153.
14. Masaoka T, Shibata H, Kakishita A, et al. Phase II study of FK 506 for allogenic bone marrow transplantation. Transplant Proc. 1991;23:3228-3231.
15. Ogawa Y, Okamoto S, Kuwana M, et al. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK 506 and corticosteroids. Cornea. 2001;20:430-434.
16. Aoki S, Mizote H, Minamoto A, et al. Systemic FK506 improved tear secretion in dry eye associated with chronic graft-versus-host disease. Br J Ophthalmol. 2005;89:243-244.
17. Merayo-Lloves J, Baltatzis S, Foster CS. Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child. Am J Ophthalmol. 2001;132:922-923.
18. Fujita M, Igarashi T, Kurai T, et al. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140:808-813.
19. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Research. 2006;82:885-898.